Publications

Results of Rearrange Trial: A Randomized Phase 2 Study Comparing Different Dosing Approaches for Regorafenib (Reg) During the First Cycle of Treatment in Patients (Pts) with Metastatic Colorectal Cancer (Mcrc)

AuthID
P-00R-SZ3

Author(s)

Argiles, G

Margalef, NM

Valladares Ayerbes, M

de Prado, JV

Grávalos, C

Alfonso, PG

Santos, C

Tobeña, M

Sastre, J

Benavides, M

Cano, T

Loupakis, F

Garrote, MR

Rivera, F

Goldberg, R

Falcone, A

Bennouna, J

Ciardiello, F

Tabernero, J

Aranda, E

Document Type

Article

Year published

2019

Published

in Annals of oncology : official journal of the European Society for Medical Oncology, ISSN: 1569-8041

Volume: 30, Pages: iv135

Indexing

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1093/annonc/mdz154.025

Pubmed: 32085044

Scopus: 2-s2.0-85079917591

Source Identifiers

ISSN: 1569-8041

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Results of Rearrange Trial: A Randomized Phase 2 Study Comparing Different Dosing Approaches for Regorafenib (Reg) During the First Cycle of Treatment in Patients (Pts) with Metastatic Colorectal Cancer (Mcrc)

Useful Links

Get Help

Federated Authentication (Click on the image)

Results of Rearrange Trial: A Randomized Phase 2 Study Comparing Different Dosing Approaches for Regorafenib (Reg) During the First Cycle of Treatment in Patients (Pts) with Metastatic Colorectal Cancer (Mcrc)

Useful Links

Get Help